[HTML] sciencedirect.com

[HTML][HTML] Targeted locus amplification (TLA): a novel next generation sequencing (NGS) technology to detect new molecular markers and monitoring minimal residual …

E Genuardi, P Klous, D Drandi, B Mantoan, L Monitillo… - Blood, 2017 - Elsevier
Background: Minimal residual disease (MRD) monitoring by PCR methods is a strong and
standardized predictor of clinical outcome in mantle cell (MCL) and follicular (FL) lymphoma …
被引用次数：3 相关文章

Targeted Locus Amplification (TLA): A Novel Next Generation Sequencing (NGS) Technology to Detect New Molecular Markers and Monitoring Minimal Residual …

E Genuardi, P Klous, D Drandi, B Mantoan, L Monitillo… - Blood, 2017 - ashpublications.org
Background: Minimal residual disease (MRD) monitoring by PCR methods is a strong and
standardized predictor of clinical outcome in mantle cell (MCL) and follicular (FL) lymphoma …